Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L1IS
|
|||
Former ID |
DNC013757
|
|||
Drug Name |
NOR-ROEFRACTINE
|
|||
Synonyms |
CHEMBL512542; NOR-ROEFRACTINE; (R)-Norroefractine; AC1OEFB1; ZINC3847479; BDBM50259928; (1R)-7-methoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-6-ol
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H21NO3
|
|||
Canonical SMILES |
COC1=CC=C(C=C1)CC2C3=CC(=C(C=C3CCN2)O)OC
|
|||
InChI |
1S/C18H21NO3/c1-21-14-5-3-12(4-6-14)9-16-15-11-18(22-2)17(20)10-13(15)7-8-19-16/h3-6,10-11,16,19-20H,7-9H2,1-2H3/t16-/m1/s1
|
|||
InChIKey |
HIMHLENXDBHLCU-MRXNPFEDSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and dopamine receptor selectivity of the benzyltetrahydroisoquinoline, (R)-(+)-nor-roefractine. J Nat Prod. 1998 Jun 26;61(6):709-12. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.